Insider · CIK 0001624925

Knudson Susan A.

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001624925

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-10	Histogen Inc.Stock Option (right to buy)D Disposition to Issuer	COO and CFO	DDisposition to Issuer	−8,490 sh	—	—	0
2023-03-10	Histogen Inc.Stock Option (right to buy)A Award	COO and CFO	AAward	+79K sh	—	—	79,027
2023-03-10	Histogen Inc.Stock Option (right to buy)A Award	COO and CFO	AAward	+27.8K sh	—	—	27,766
2023-03-10	Histogen Inc.Stock Option (right to buy)D Disposition to Issuer	COO and CFO	DDisposition to Issuer	−6,206 sh	—	—	0
2023-03-10	Histogen Inc.Stock Option (right to buy)D Disposition to Issuer	COO and CFO	DDisposition to Issuer	−5,600 sh	—	—	0
2022-11-07	Histogen Inc.Restricted Stock UnitsD Disposition to Issuer	COO and CFO	DDisposition to Issuer	−6,858 sh	$250.00	−$1.71M	0
2022-02-17	Histogen Inc.Stock Option (right to buy)A Award	COO and CFO	AAward	+170K sh	—	—	169,800
2021-11-08	Histogen Inc.Restricted Stock UnitA Award	COO and CFO	AAward	+137K sh	—	—	137,174
2021-01-13	Histogen Inc.Stock Option (right to buy)A Award	COO and CFO	AAward	+112K sh	—	—	112,000
2020-05-28	Histogen Inc.Stock Option (right to buy)A Award	COO and CFO	AAward	+124K sh	—	—	124,119
2019-02-01	Pfenex Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+59K sh	—	—	59,000
2018-03-01	Pfenex Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+144K sh	—	—	143,500
2017-06-22	EVFMEvofem Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2017-03-02	EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2016-02-04	EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2015-12-17	EVFMEvofem Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−1,005 sh	$1.26	−$1,266.3	0
2015-09-01	EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	—	—	30,718
2015-09-01	EVFMEvofem Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$1.22	+$3,660	3,492
2015-09-01	EVFMEvofem Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−3,000 sh	$11.33	−$34K	492
2015-02-10	EVFMEvofem Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+45.6K sh	—	—	45,607

Recent filings

Accepted (ET)
Mar 144
Knudson Susan A.0001209191-23-018477
SEC(opens sec.gov)
Nov 94
Knudson Susan A.0001209191-22-056215
SEC(opens sec.gov)
Feb 224
Knudson Susan A.0001209191-22-011914
SEC(opens sec.gov)
Nov 104
Knudson Susan A.0001209191-21-063873
SEC(opens sec.gov)
Jan 154
Knudson Susan A.0001209191-21-003750
SEC(opens sec.gov)
May 294
Knudson Susan A.0000899243-20-014546
SEC(opens sec.gov)
Feb 44
Knudson Susan A.0000899243-19-002489
SEC(opens sec.gov)
Mar 14
Knudson Susan A.0000899243-18-005994
SEC(opens sec.gov)
Jun 234
Neothetics, Inc.0001209191-17-041633
SEC(opens sec.gov)
Mar 64
Neothetics, Inc.0001618835-17-000001
SEC(opens sec.gov)
Feb 84
Neothetics, Inc.0001209191-16-096460
SEC(opens sec.gov)
Dec 214
Neothetics, Inc.0001209191-15-086398
SEC(opens sec.gov)
Sep 34
Neothetics, Inc.0001209191-15-069481
SEC(opens sec.gov)
Feb 124
Neothetics, Inc.0001209191-15-013104
SEC(opens sec.gov)

Companies

Address

9191 TOWNE CENTRE DRIVE SUITE 400

SAN DIEGO, CA, 92122